Literature DB >> 16640704

Coronary flow velocity reserve measurement in three major coronary arteries using transthoracic Doppler echocardiography.

Eriko Murata1, Takeshi Hozumi, Yoshiki Matsumura, Kohei Fujimoto, Kenichi Sugioka, Yasuhiko Takemoto, Hiroyuki Watanabe, Hiroyuki Yamagishi, Minoru Yoshiyama, Hiroshi Iwao, Junichi Yoshikawa.   

Abstract

BACKGROUND: Measurement of the coronary flow velocity reserve (CFVR) by transthoracic Doppler echocardiography (TTDE) has been reported to be useful for the noninvasive assessment of significant coronary artery stenosis or myocardial ischemia. The purpose of this study was to evaluate the value of this method in three major coronary arteries for detecting myocardial ischemia in the clinical setting.
METHODS: We studied 89 consecutive patients who were referred to our outpatient clinic because of chest pain. We measured CFVR using TTDE in three major coronary arteries. We defined CFVR<2.0 in at least one vessel as being positive for myocardial ischemia. The accuracy of CFVR measurements for detecting myocardial ischemia was determined in comparison with exercise thallium-201 (Tl-201) single photon emission computed tomography (SPECT) as a reference standard.
RESULTS: CFVR in at least one vessel was successfully measured in 87 of 89 patients (98%). The sensitivity and specificity of CFVR<2.0 in at least one coronary vessel, in any of the coronary territories, was 86% and 89%, respectively. In terms of assessing myocardial ischemia in each coronary artery territory, the agreement between CFVR<2.0 and Tl-201 SPECT for the left anterior descending coronary artery, the posterior descending coronary artery, and the left circumflex coronary artery territories was 95%, 81%, and 73%, respectively.
CONCLUSION: Noninvasive CFVR measurement by TTDE may be useful for detecting myocardial ischemia, as well as for identifying ischemic territories in the clinical setting.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16640704     DOI: 10.1111/j.1540-8175.2006.00206.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  7 in total

Review 1.  Coronary Flow Velocity Reserve Assessment with Transthoracic Doppler Echocardiography.

Authors:  Iana Simova
Journal:  Eur Cardiol       Date:  2015-07

2.  Non-invasive detection of concomitant coronary artery anomaly and atherosclerotic coronary disease using transthoracic Doppler echocardiography.

Authors:  Barbara Uznanska-Loch; Michal Plewka; Jan Z Peruga; Maria Krzeminska-Pakula; Jaroslaw D Kasprzak
Journal:  Arch Med Sci       Date:  2012-02-29       Impact factor: 3.318

3.  Feasibility of 3D4D echocardiography for the detection of colour-coded flow in the left anterior descending artery.

Authors:  Stephan Stoebe; Dietrich Pfeiffer; Andreas Hagendorff
Journal:  Echo Res Pract       Date:  2014-07-23

4.  Coronary flow velocity reserve during dobutamine stress echocardiography.

Authors:  José Sebastião de Abreu; José Wellington Oliveira Lima; Tereza Cristina Pinheiro Diógenes; Jordana Magalhães Siqueira; Nayara Lima Pimentel; Pedro Sabino Gomes Neto; Marília Esther Benevides de Abreu; José Nogueira Paes Júnior
Journal:  Arq Bras Cardiol       Date:  2013-12-21       Impact factor: 2.000

5.  Distal left circumflex coronary artery flow reserve recorded by transthoracic Doppler echocardiography: a comparison with Doppler-wire.

Authors:  Antonio Auriti; Christian Pristipino; Cinzia Cianfrocca; Antonino Granatelli; Vincenzo Guido; Francesco Pelliccia; Salvatore Greco; Giuseppe Richichi; Massimo Santini
Journal:  Cardiovasc Ultrasound       Date:  2007-06-16       Impact factor: 2.062

Review 6.  Coronary flow reserve from mouse to man--from mechanistic understanding to future interventions.

Authors:  Li-Ming Gan; Johannes Wikström; Regina Fritsche-Danielson
Journal:  J Cardiovasc Transl Res       Date:  2013-07-23       Impact factor: 4.132

7.  Remote ischemic conditioning improves coronary microcirculation in healthy subjects and patients with heart failure.

Authors:  Yasushi Kono; Shota Fukuda; Akihisa Hanatani; Koki Nakanishi; Kenichiro Otsuka; Haruyuki Taguchi; Kenei Shimada
Journal:  Drug Des Devel Ther       Date:  2014-08-27       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.